Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Rash
ADR ID BADD_A03695
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.13      Rashes, eruptions and exanthems NEC
23.03.13.001      Rash
Description Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology. [MeSH]
MedDRA Code 10037844
MeSH ID D005076
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Dry rash face | Dry rash neck | Eruption | Eruption facial | Eruption of limbs | Exanthem | Exanthema | Extensive rash of forearm | Extensive rash of legs | Facial rash | Generalised eruption | Generalised rash | Hand rash | Neck rash | Patchy rash | Rash | Rash (nonspecific) | Rash all over | Rash both legs | Rash face | Rash generalised | Rash in the outer ear | Rash NOS | Rash on face | Rash on legs & arms | Rash over arms | Rash trunk & limbs | Skin eruption | Skin rash | Widespread non-itchy dull red patchy rash | Widespread rash | Rash aggravated | Generalized rash | Periocular rash | Efflorescence | Exanthema generalised | Exanthema facial | Exanthema generalized | Rash trunk | Generalized eruption | Localised rash | Localized rash | Rash peripheral | Rash recurrent | Palmoplantar rash | Painful rash | Pigmented rash | Rash on leg | Scalp rash | Skin breakout | Periorbital rash | Evanescent skin rash | Groin rash | Hypopigmented rash | Skin Rash | Rash, Skin
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01295Linezolid--
BADD_D01296Liothyronine0.002118%
BADD_D01298Liraglutide--
BADD_D01299Lisdexamfetamine dimesylate--
BADD_D01300Lisinopril--
BADD_D01302Lithium--
BADD_D01303Lithium carbonate--
BADD_D01304Lithium cation--
BADD_D01305Lithium hydroxide--
BADD_D01307Lodoxamide--
BADD_D01308Lodoxamide tromethamine--
BADD_D01309Lomefloxacin--
BADD_D01310Lomefloxacin hydrochloride--
BADD_D01314Loperamide cation--
BADD_D01315Loperamide hydrochloride--
BADD_D01316Loracarbef--
BADD_D01317Loratadine0.000685%
BADD_D01318Lorazepam--
BADD_D01319Lorcaserin hydrochloride--
BADD_D01320Lorcaserin hydrochloride hemihydrate--
BADD_D01321Lormetazepam--
BADD_D01322Losartan--
BADD_D01323Losartan potassium--
BADD_D01324Loteprednol etabonate0.004149%
BADD_D01325Lovastatin--
BADD_D01326Loxapine--
BADD_D01327Loxapine succinate--
BADD_D01328Lubiprostone--
BADD_D01330Lurasidone--
BADD_D01331Lurasidone hydrochloride--
The 32th Page    First    Pre   32 33 34 35 36    Next   Last    Total 60 Pages
ADReCS-Target
ADR Term Drug Name Target